Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation
2011 · Blood · 308 citations
https://doi.org/10.1182/blood-2011-08-375840
P
Per Ljungman
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
787
Papers
49.5K
Citations
110
h-index
509
i10-index
Per Ljungman is an academic researcher from Karolinska University Hospital. The author has contributed to research in topics: Hematopoietic Stem Cell Transplantation & Cytomegalovirus and herpesvirus research & Polyomavirus and related diseases. The author has an h-index of 110, co-authored 669 publications.
ORCID: 0000-0002-8281-3245Papers by this author
worksPoor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group
2021 · Leukemia · 113 citations
https://doi.org/10.1038/s41375-021-01466-0
Introduction of a Quality Management System and Outcome After Hematopoietic Stem-Cell Transplantation
2011 · Journal of Clinical Oncology · 101 citations
https://doi.org/10.1200/jco.2010.30.4121
Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee
2020 · Biology of Blood and Marrow Transplantation · 61 citations
https://doi.org/10.1016/j.bbmt.2020.07.021
Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplant Research
2016 · Biology of Blood and Marrow Transplantation · 60 citations
https://doi.org/10.1016/j.bbmt.2016.05.026
Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma
2022 · Cell Reports Medicine · 55 citations
https://doi.org/10.1016/j.xcrm.2022.100508
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat